Does EBV persist in memory B cells and do VCA IgG plus EBNA IgG indicate prior infection?

EBV is a near-universal persistent herpesvirus infection. The claim accurately distinguishes its usual latent reservoir from what routine antibody testing can—and cannot—show.

Persistence and mechanism

• After primary infection, EBV generally persists lifelong in a latent, largely transcriptionally silent state, chiefly in resting memory B cells. The viral genome is retained as a nuclear episome and maintained as infected host cells divide.
• Human tonsil and peripheral-blood findings support entry of infected B cells into the antigen-experienced memory compartment. Reduced viral gene expression during latency helps limit immune recognition.
• Latency is not permanent biological inactivity. When infected memory B cells differentiate toward antibody-secreting/plasma cells, lytic reactivation can occur, allowing viral replication and shedding. Resting memory B cells are the principal long-term reservoir, though not necessarily the only infected cellular population.

Serologic interpretation

• Concurrent VCA IgG and EBNA-1 IgG positivity is the established pattern of prior EBV infection, particularly if VCA IgM is negative. VCA IgG develops during infection and commonly persists for life; EBNA IgG develops later and also generally persists.
• This pattern does not establish active viral replication, reactivation, or symptomatic EBV disease. Antibody level or magnitude does not reliably determine when infection occurred or whether the virus is currently active.

Clinical implications

• Symptoms, immune status, and the broader clinical setting determine whether further assessment is warranted. EBV DNA PCR may be useful selectively—especially with immunocompromise or suspected EBV-associated disease—but its meaning depends on specimen type and context; detection alone is not synonymous with lytic replication.

Bottom line

• The claim is well supported: EBV usually remains latent for life primarily in memory B cells, while VCA IgG plus EBNA IgG chiefly documents previous exposure rather than proving ongoing EBV replication.